FDS Stock Analysis: FactSet Research Systems | NYSE
Financial Data & Stock Exchanges | NYSE, USA | Market Cap: 9.873m USD | 12M Return: 3.6% | US3030751057 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 216M
EPS Trend: 94.1%
Qual. Beats: 1
Rev. Trend: 99.7%
Qual. Beats: 6
Warnings
No concerns identified
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
FactSet Research Systems Inc. (NYSE: FDS) is a financial data and analytics platform serving the global investment community. The company provides data products, workstations, portfolio analytics, enterprise data solutions, and managed services supporting investment research, portfolio construction, trade execution, performance measurement, risk management, and reporting workflows. Its offerings are delivered through configurable desktop and mobile platforms, data feeds, cloud-based solutions, and application programming interfaces, with subscription-based access to market intelligence on securities, companies, industries, and people.
FactSets client base includes institutional asset managers, bankers, wealth managers, asset owners, hedge funds, corporate users, and private equity and venture capital professionals, with operations spanning the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company maintains a strategic partnership with Google Cloud to develop AI-powered solutions for the financial industry. Founded in 1978 and headquartered in Norwalk, Connecticut, FactSet operates in the Financial Exchanges & Data sub-industry alongside other major market data and index providers.
- Subscription revenue growth reaccelerates as ASV exceeds guidance
- Google Cloud AI partnership accelerates workflow product roadmap
- Competitive pricing pressure from Bloomberg and LSEG caps margin expansion
| Net Income: 533.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 2.73 > 1.0 |
| NWC/Revenue: -17.67% < 20% (prev 8.98%; Δ -26.65% < -1%) |
| CFO/TA 0.20 > 3% & CFO 822.2m > Net Income 533.5m |
| Net Debt (1.49b) to EBITDA (915.4m): 1.63 < 3 |
| Current Ratio: 0.60 > 1.5 & < 3 |
| Outstanding Shares: last quarter (35.6m) vs 12m ago -6.78% < -2% |
| Gross Margin: 50.61% > 18% (prev 52.72%; Δ -2.11% > 0.5%) |
| Asset Turnover: 58.63% > 50% (prev 53.94%; Δ 4.69% > 0%) |
| Interest Coverage Ratio: 8.62 > 6 (EBIT TTM 702.3m / Interest Expense TTM 81.5m) |
| A: -0.11 (Total Current Assets 654.7m - Total Current Liabilities 1.09b) / Total Assets 4.14b |
| B: 0.63 (Retained Earnings 2.61b / Total Assets 4.14b) |
| C: 0.17 (EBIT TTM 702.3m / Avg Total Assets 4.22b) |
| D: 0.94 (Book Value of Equity 2.00b / Total Liabilities 2.14b) |
| Altman-Z'' = 3.46 = A |
| DSRI: 1.04 (Receivables 301.4m/270.7m, Revenue 2.48b/2.32b) |
| GMI: 1.04 (GM 52.72% / 50.61%) |
| AQI: 1.02 (AQ_t 0.80 / AQ_t-1 0.78) |
| SGI: 1.07 (Revenue 2.48b / 2.32b) |
| TATA: -0.07 (NI 533.5m - CFO 822.2m) / TA 4.14b) |
| Beneish M = -2.90 (Cap -4..+1) = A |
As of October 09, 2026, the stock is trading at USD 286.52 with a total of 1,128,521 shares traded. Over the past week, the price has changed by +3.21%, over one month by -0.86%, over three months by +16.05% and over the past year by +3.62%.
Current recommended Stop Loss: 270.40 (which is 5.6% or 1.4 ATR below the current price).
FactSet Research Systems has received a consensus analysts rating of 2.78. Therefore, it is recommended to hold FDS.
- StrongBuy: 3
- Buy: 0
- Hold: 9
- Sell: 2
- StrongSell: 4
| Analysts Target Price | 277.6 | -3.1% |
P/E Trailing = 18.5197
P/E Forward = 13.947
P/S = 3.9872
P/B = 4.8901
P/EG = 1.2237
Revenue TTM = 2.48b USD
EBIT TTM = 702.3m USD
EBITDA TTM = 915.4m USD
Long Term Debt = 890.5m USD (from longTermDebt, two quarters ago)
Short Term Debt = 533.7m USD (from shortTermDebt, last quarter)
Debt = 1.72b USD (from shortLongTermDebtTotal, last quarter) + Leases 180.9m
Net Debt = 1.49b USD (calculated: Debt 1.72b - CCE 233.3m)
Enterprise Value = 11.4b USD (9.87b + Debt 1.72b - CCE 233.3m)
Interest Coverage Ratio = 8.62 (Ebit TTM 702.3m / Interest Expense TTM 81.5m)
EV/FCF = 16.06x (Enterprise Value 11.4b / FCF TTM 707.5m)
FCF Yield = 6.23% (FCF TTM 707.5m / Enterprise Value 11.4b)
FCF Margin = 28.57% (FCF TTM 707.5m / Revenue TTM 2.48b)
Net Margin = 21.54% (Net Income TTM 533.5m / Revenue TTM 2.48b)
Gross Margin = 50.61% ((Revenue TTM 2.48b - Cost of Revenue TTM 1.22b) / Revenue TTM)
Gross Margin QoQ = 48.59% (prev 49.88%)
Tobins Q-Ratio = 2.74 (Enterprise Value 11.4b / Total Assets 4.14b)
Interest Expense / Debt = 4.73% (Interest Expense 81.5m / Debt 1.72b)
Taxrate = 17.89% (116.2m / 649.7m)
NOPAT = 576.6m (EBIT 702.3m * (1 - 17.89%))
Current Ratio = 0.60 (Total Current Assets 654.7m / Total Current Liabilities 1.09b)
Debt / Equity = 0.86 (Debt 1.72b / totalStockholderEquity, last quarter 2.00b)
Debt / EBITDA = 1.63 (Net Debt 1.49b / EBITDA 915.4m)
Debt / FCF = 2.11 (Net Debt 1.49b / FCF TTM 707.5m)
Total Stockholder Equity = 2.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.63% (Net Income 533.5m / Total Assets 4.14b)
RoE = 25.61% (Net Income TTM 533.5m / Total Stockholder Equity 2.08b)
RoCE = 23.62% (EBIT 702.3m / Capital Employed (Equity 2.08b + L.T.Debt 890.5m))
RoIC = 16.66% (NOPAT 576.6m / Invested Capital 3.46b)
WACC = 6.26% (E(9.87b)/V(11.6b) * Re(6.67%) + D(1.72b)/V(11.6b) * Rd(4.73%) * (1-Tc(0.18)))
Discount Rate = 6.67% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -89.27 | Cagr: -3.61%
[DCF] Terminal Value 77.91% ; FCFF base≈671.5m ; Y1≈767.0m ; Y5≈1.12b
[DCF] Fair Price = 431.8 (EV 16.8b - Net Debt 1.49b = Equity 15.4b / Shares 35.6m; r=8.35% [WACC [floored]]; 5y FCF grow 14.58% → 2.50% )
EPS Correlation: 94.15 | EPS CAGR: 6.65% | SUE: 2.54 | # QB: 1
Revenue Correlation: 99.72 | Revenue CAGR: 5.72% | SUE: 1.39 | # QB: 6
EPS current Quarter (2026-11-30): EPS=5.00 | Chg30d=+1.25% | Revisions=+25% | Analysts=16
EPS next Quarter (2027-02-28): EPS=4.91 | Chg30d=+0.18% | Revisions=+25% | Analysts=16
EPS current Year (2027-08-31): EPS=19.63 | Chg30d=-0.43% | Revisions=+25% | GrowthEPS=+9.0% | GrowthRev=+5.8%
EPS next Year (2028-08-31): EPS=21.72 | Chg30d=-0.88% | Revisions=-25% | GrowthEPS=+10.7% | GrowthRev=+5.9%
[Analyst] Revisions Ratio: +29% (up=3, down=1)